Radiation Therapy Treatment Study for Patients with Limited-Stage Small Cell Lung Cancer

Clinical Trial Title

Phase III comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide.

Contact Information

Rush Cancer Center Clinical Trials Office

Clinical Trial Protocol Description:

Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as etoposide, carboplatin and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. It is not yet known which radiation therapy regimen is more effective when given together with chemotherapy in treating patients with limited-stage small cell lung cancer. This randomized phase III trial is comparing different chest radiation therapy regimens to see how well they work in treating patients with limited-stage small cell lung cancer.

Clinical Trial Eligibility Criteria:

In order to participate you must meet the following criteria:

  • Have limited stage small cell lung cancer.
  • Have received one and only one cycle of chemotherapy for small cell lung cancer.
  • Have no prior radiotherapy for small cell lung cancer.

You will be excluded from the study if any of the following criteria apply to you:

  • Have had complete surgical removal of disease.

This is a partial list of elgibility requirements. To inquire about your eligibility, please call the contact number provided.

Study Details

Clinical Trial Investigator

Gaurav Marwaha, MD

Contact Information

Rush Cancer Center Clinical Trials Office

Location

Rush University Medical Center

1620 W Harrison St
Chicago, IL 60612

Get Directions

Clinical Trial FAQs

Find out if a clinical trial makes sense for you.

Learn more
Learn more